C16orf88 Inhibitors
The diverse group of chemicals classified as C16orf88 Inhibitors reflects a broader approach to modulate cellular pathways potentially related to C16orf88 function. Compounds like Y-27632, which targets ROCK, can influence cellular dynamics, possibly countering C16orf88's presumptive roles in cellular motility or structure. By halting key pathways such as MAPK/ERK with PD98059 or PI3K/Akt with Wortmannin and LY294002, cellular growth, differentiation, and survival can be directly challenged, offering the possibility to change the influence or function of C16orf88.
On the other hand, modulators like IWP-2, which inhibits Wnt secretion, and Dorsomorphin, which targets BMP signaling, offer avenues to adjust cellular signaling pathways related to development, differentiation, and tissue homeostasis. C16orf88 is implicated in such pathways, these inhibitors serve as tools to study or manipulate its function. Similarly, MG132 and Rapamycin address protein dynamics within the cell, from degradation to synthesis, providing additional methods to explore the life cycle and function of proteins like C16orf88.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Inhibits ROCK, which can influence cell motility and morphology, potentially impacting any role C16orf88 plays in these processes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
A MEK inhibitor affecting the MAPK/ERK pathway, which regulates various cellular processes, including cell growth and differentiation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3K inhibitor, disrupting downstream Akt signaling which plays a role in cell survival and growth. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Another PI3K inhibitor that modulates the PI3K/Akt pathway, possibly affecting cellular environments involving C16orf88. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inhibits p38 MAPK, affecting cellular responses to stress and potentially modifying any stress-response role of C16orf88. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor which disrupts its downstream actions on factors like c-Jun. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $94.00 $286.00 | 27 | |
Inhibits Wnt processing, thereby preventing Wnt secretion and affecting Wnt signaling pathways. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $150.00 $349.00 | 15 | |
Aurora kinase inhibitor affecting chromosome alignment and segregation during cell division. | ||||||
Dorsomorphin dihydrochloride | 1219168-18-9 | sc-361173 sc-361173A | 10 mg 50 mg | $182.00 $736.00 | 28 | |
BMP signaling inhibitor which can disrupt cellular differentiation processes. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
Proteasome inhibitor that affects protein degradation, potentially influencing C16orf88 protein turnover. | ||||||